Jane Street Group, LLC Aldeyra Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 16, 2022	SELL	$2.43 - $4.85 $203,391 - $405,944	-83,700 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$3.25 - $5.17 $157,625 - $250,745	-48,500 Reduced 36.69%	83,700 $372,000
Q4 2021 Feb 15, 2022	BUY	$3.5 - $9.63 $412,300 - $1.13 Million	117,800 Added 818.06%	132,200 $529,000
Q3 2021 Nov 16, 2021	SELL	$7.94 - $11.31 $8,734 - $12,441	-1,100 Reduced 7.1%	14,400 $126,000
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $161,820 - $230,175	15,500 New	15,500 $176,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.